JP2006514051A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006514051A5 JP2006514051A5 JP2004565376A JP2004565376A JP2006514051A5 JP 2006514051 A5 JP2006514051 A5 JP 2006514051A5 JP 2004565376 A JP2004565376 A JP 2004565376A JP 2004565376 A JP2004565376 A JP 2004565376A JP 2006514051 A5 JP2006514051 A5 JP 2006514051A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- unsubstituted
- disubstituted
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims 5
- 125000005843 halogen group Chemical group 0.000 claims 4
- 239000003064 xanthine oxidase inhibitor Substances 0.000 claims 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 3
- 125000003277 amino group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 2
- 210000004165 Myocardium Anatomy 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 125000004701 alkyl carbonyl alkyl carbonyl group Chemical group 0.000 claims 2
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 claims 2
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 1
- 125000004442 acylamino group Chemical group 0.000 claims 1
- 125000004103 aminoalkyl group Chemical group 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 125000005324 aryloxy alkyloxy group Chemical group 0.000 claims 1
- 125000004429 atoms Chemical group 0.000 claims 1
- 230000000747 cardiac effect Effects 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 0 *C1SC(CC2CC2)=*C(*)=C1 Chemical compound *C1SC(CC2CC2)=*C(*)=C1 0.000 description 1
Claims (4)
- CHF患者に治療有効量のキサンチンオキシダーゼ阻害剤化合物を投与することを含む、前記患者の心筋中の高エネルギーリン酸分子濃度を高めることによる前記患者の心収縮性の改善方法。
- CHF患者に対してキサンチンオキシダーゼ阻害剤化合物を投与することを含む前記患者の心筋中の高エネルギーリン酸濃度の増加方法。
- CHF患者に対して治療有効量のキサンチンオキシダーゼ阻害剤化合物を投与することを含むCHFの治療方法。
- キサンチンオキシダーゼ阻害剤化合物が式(I):
Arは未置換または置換フリル基、または式(II):
で表される基であり、
Xは水素原子、C1−14アルキル基、カルボキシ基、C1−5アルコキシカルボニル基、カルバモイル基、C1−4アルキル(モノまたはジ置換)アミノカルボニル基、またはCOOR9(ここで、R9はC1−4アルキル基である)であり、
Yは水素原子、C1−4アルキル基、カルボキシ基、C1−5アルコキシカルボニル基、カルバモイル基またはC1−4アルキル(モノまたはジ置換)アミノカルボニル基を表し、
ただしR1、R2及びR3の少なくとも1個の基がハロゲン原子、アルコキシ基、アルキルアミノ基またはニトロ基を表すとき、他の2個の基のうちの少なくとも1個は水素原子以外の基を表し、R1、R2及びR3の少なくとも1個の基がハロゲン原子で別の基が水素原子のとき、残りの基はハロゲン原子、アルコキシ基、アルキルアミノ基またはアシルアミノ基以外の基であり、
ただしR1、R2またはR3の1個がOR4のとき、残りの基の1個は水素を表すことができず、他の基はOR4を表すかまたは残りの2個の基がいずれも同時にOR4を表すことができず、R1〜R3のすべてがハロゲンを表さず、
ただしX及びYの両方が同時にカルボキシ基、C1−5アルコキシカルボニル基、カルバモイル基またはC1−4アルキル(モノまたはジ置換)アミノカルボニル基を表さない]
を有する化合物またはその医薬的に許容され得る塩である請求の範囲第1項に記載の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/325,420 US20040122067A1 (en) | 2002-12-20 | 2002-12-20 | Treatment of chronic heart failure |
PCT/US2003/039410 WO2004060489A2 (en) | 2002-12-20 | 2003-12-11 | Treatment of chronic heart failure |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006514051A JP2006514051A (ja) | 2006-04-27 |
JP2006514051A5 true JP2006514051A5 (ja) | 2007-02-01 |
Family
ID=32593758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004565376A Pending JP2006514051A (ja) | 2002-12-20 | 2003-12-11 | 慢性心不全の治療 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20040122067A1 (ja) |
EP (1) | EP1581308A2 (ja) |
JP (1) | JP2006514051A (ja) |
CA (1) | CA2506719A1 (ja) |
MX (1) | MXPA05006628A (ja) |
PL (1) | PL375893A1 (ja) |
WO (1) | WO2004060489A2 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005027887A2 (en) * | 2003-09-17 | 2005-03-31 | Cardimone Pharma Corporation | Methods and compositions for improving endothelial function |
CA2607953A1 (en) * | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
EP2101761A4 (en) * | 2006-11-13 | 2010-01-27 | Takeda Pharmaceuticals North A | METHODS FOR PRESERVING RENAL FUNCTION USING XANTHINE OXYDOREDUCTASE INHIBITORS |
US20090124623A1 (en) * | 2006-11-13 | 2009-05-14 | Christopher Lademacher | Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors |
KR20090127870A (ko) * | 2007-01-19 | 2009-12-14 | 다케다 파마슈티칼스 노쓰 어메리카, 인코포레이티드 | 크산틴 산화환원효소 저해제들 및 항염증제들을 사용하여 통풍 발열을 방지하거나 또는 통풍 발열의 회수를 감소시키는 방법 |
US20100311756A1 (en) * | 2009-01-22 | 2010-12-09 | Takeda Pharmaceuticals North America, Inc. | Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof |
GB0909243D0 (en) * | 2009-05-29 | 2009-07-15 | Univ Dundee | Angina treatment |
IT1400311B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso. |
IT1400310B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e statine e loro uso. |
IT1400309B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso. |
IT1400609B1 (it) | 2010-05-10 | 2013-06-14 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e metformina e loro uso. |
CN103298466B (zh) | 2010-09-10 | 2015-11-25 | 武田制药美国有限公司 | 茶碱和非布索坦的联合治疗方法 |
JP6134072B2 (ja) * | 2014-07-30 | 2017-05-24 | 帝人ファーマ株式会社 | キサンチンオキシダーゼ阻害薬 |
WO2016133069A1 (ja) * | 2015-02-17 | 2016-08-25 | 株式会社 三和化学研究所 | 心不全の予防又は治療のための医薬 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE122008000051I1 (de) * | 1990-11-30 | 2009-02-05 | Teijin Ltd | 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel |
AU1520699A (en) * | 1997-11-07 | 1999-05-31 | Johns Hopkins University, The | Methods for treatment of disorders of cardiac contractility |
CN1215076C (zh) * | 1998-09-09 | 2005-08-17 | 症变治疗公司 | 新的果糖1,6-二磷酸酶的杂芳族抑制剂 |
PT1121111E (pt) * | 1998-10-15 | 2010-05-17 | Imp Innovations Ltd | Compostos para o tratamento de perda de peso |
ES2288847T3 (es) * | 1999-03-09 | 2008-02-01 | Anker, Stefan | Uso de inhibidores de endotoxina para el tratamiento de la caquexia. |
-
2002
- 2002-12-20 US US10/325,420 patent/US20040122067A1/en not_active Abandoned
-
2003
- 2003-12-11 JP JP2004565376A patent/JP2006514051A/ja active Pending
- 2003-12-11 CA CA002506719A patent/CA2506719A1/en not_active Abandoned
- 2003-12-11 WO PCT/US2003/039410 patent/WO2004060489A2/en not_active Application Discontinuation
- 2003-12-11 EP EP03796950A patent/EP1581308A2/en not_active Withdrawn
- 2003-12-11 MX MXPA05006628A patent/MXPA05006628A/es unknown
- 2003-12-11 PL PL03375893A patent/PL375893A1/xx unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2006514051A5 (ja) | ||
JP2020505396A5 (ja) | ||
JP2018507197A5 (ja) | ||
JP2019512478A5 (ja) | ||
RU2006112593A (ru) | Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70 и/или syk | |
RU2006134003A (ru) | Серосодержащие соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с | |
JP2008533191A5 (ja) | ||
RU2003132687A (ru) | Лечение диабета типа 2 ингибиторами дипептидилпептидазы iv | |
JP2006143737A5 (ja) | ||
HUP0201088A2 (hu) | Új alfa-aminosav-szulfonil-vegyületek, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
HUP0100950A2 (hu) | Ciklusos aminovegyületek, alkalmazásuk gyógyászati készítmények előállítására és a vegyületeket tartalmazó gyógyászati készítmények | |
RU2003116123A (ru) | Амидоэфирзамещенные имидазохинолины | |
JP2004537564A5 (ja) | ||
RU2007130144A (ru) | Гетероциклические соединения в качестве антагонистов cccr2b | |
RU2008119692A (ru) | Новые 1-азабициклоалкилпроизводные для лечения психических растройств | |
JP2005539088A5 (ja) | ||
CA2671071A1 (en) | Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof | |
RU2005114021A (ru) | Производные имидазола и их применение в качестве периферически-селективных ингибиторов дофамин-бета-гидролазы | |
RU2008119465A (ru) | Производные циклопропилуксусной кислоты и их применение | |
RU2007125130A (ru) | Применение атазанавира для улучшения фармакокинетики лекарственных средств, метаболизируемых ugt1a1 | |
CA2539349A1 (en) | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones | |
JP2012513390A5 (ja) | ||
TNSN05080A1 (en) | NOVEL ANTIMYCOBACTERIAL COMPOUNDS (as filed) AND PYRROLE DERIVATIVES AS ANTIMYCOBACTERIAL COMPOUNDS (as published) | |
CA2458025A1 (en) | Novel 4-aminofuropyrimidines and the use thereof | |
JP2005526794A5 (ja) | ベンズイミダゾールおよびマイトジェン活性化およびrhoキナーゼ阻害剤としてのその使用 |